Clinical Trial Update: Study to Assess the Tolerability and the Safety of the Transition From Inhaled Treprostinil to Oral Selexipag in Patients With Pulmonary Arterial Hypertension [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating tolerability and safety of transitioning from inhaled treprostinil to oral selexipag in patients with pulmonary arterial hypertension; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• Selexipag (selexipag)
• Treprostinil (treprostinil)

Snippet

Sponsor: Actelion | Conditions: Pulmonary Arterial Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2017-12-28